https://scienztech.org/index.php/ijds <p>International Journal of Dermatopathology and Surgery came into existence on the 28th of January 2020. Initially, scienztech.org . Over the years, numbers of members in both states increased and Scienztech.org decided to form their own state branches andscienztech.org was officially formed in 2019.<br>scienztech.org a vibrant state branch with many awards and accolades to its credit. Besides conducting many scientific meetings to the benefit of its members, scienztech.org is fore runner when it comes to the public awareness campaigns such as scienztech.org a which was well accepted and appreciated by the public.&nbsp;</p> <p><strong>FOCUS AND SCOPE</strong></p> <p>This journal involves basic clinical and non-clinical studies related to dermatopathology, pathological sciences and surgery. This journal mainly focuses on the articles related to the studies of implication of dermatopathology and surgery and their impact on pharmacology, physiology, biology and disease management. This journal also covers skin biology and common disorders, skin diseases in pregnancy, childhood, adolescence and old age, moles, skin cancers, infections and infestations, skin systemic disease, hair, nails and oral lesions and clinical practice.</p> <p>Preference will be given to the articles containing clinical interests and their implications that apply dermatopathology and surgery.</p> International Journal of Dermatopathology and Surgery, Sponsored by ScienzTech en-US International Journal of Dermatopathology and Surgery 2455-247X <p><a href="http://creativecommons.org/licenses/by-nc-sa/4.0/" rel="license"><img style="border-width: 0;" src="https://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png" alt="Creative Commons License"></a><br>This work is licensed under a <a href="http://creativecommons.org/licenses/by-nc-sa/4.0/" rel="license">Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License</a>. <span style="font-weight: 400;">Copyright @2017. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (</span><a href="http://creativecommons.org/licenses/by-nc-sa/4.0/"><span style="font-weight: 400;">http://creativecommons.org/licenses/by-nc-sa/4.0/</span></a><span style="font-weight: 400;">) which permits unrestricted non-commercial used, distribution and reproduction in any medium </span></p> https://scienztech.org/index.php/ijds/article/view/1275 <p>Tuberculosis causes most number of deaths due to infections worldwide. Around 9.0 million new cases and 1.5 million deaths registered worldwide of which 360,000 were HIV positive. One fourth of the global TB encumbrance occurs in India, making it the most important public health problem facing this country. It is estimated that out of 9.0 million cases worldwide, 2.3 million cases were reported in India. TB control program of India is on track as far as reduction in the disease burden. There is 42% lessening in humanity since 1990 and 51% lessening in TB pervasiveness as associated to 1990. Further, TB pervasiveness has concentrated from 40 lakhs to 28 lakhs annually from 1990. A total of 9,28,190 smear positive TB cases were diagnosed and 14,10,880 were registered for treatment under RNTCP. It has become a major barrier to our socioeconomic development. Tuberculosis (TB) still remains as the most common communicable disease. It is estimated that 21% of the global TB burden occurs in India. Two in every five Indians are infected with tuberculosis and two persons die every minute because of tuberculosis in India. This study focuses to study the clinico-radiological profile of treated pulmonary tuberculosis patients and to evaluate the risk factors that can influence the treatment outcome in a tertiary care hospital and to evaluate the type of limitation in lung function by spirometry in treated pulmonary tuberculosis patients.</p> Vishal N Kushare Suvarna A Wagh Copyright (c) 2020 https://creativecommons.org/licenses/by-nc-nd/4.0/ 2020-07-06 2020-07-06 6 2 17 22 10.26452/ijds.v6i2.1275